Trials / Active Not Recruiting
Active Not RecruitingNCT06231238
Balance Acceptance and Commitment Therapy for Long COVID
A Randomised Controlled Trial Assessing the Efficacy of Balance Acceptance and Commitment Therapy (ACT) for Long COVID.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Balance Acceptance and Commitment Therapy | Balance-ACT is an ACT-based psychological intervention specifically designed for people with PCS/LC. Balance-ACT will use ACT techniques and mindfulness and will focus on establishing a balance psychologically and physiologically and regulating homeostasis. More specifically, Balance ACT will aim to regulate behaviours such as sleep, stress and activity, which can subsequently have an impact on homeostasis and physiology. Balance-ACT will also encourage people to live a values-based life and set goals according to their values. |
Timeline
- Start date
- 2024-06-04
- Primary completion
- 2026-04-14
- Completion
- 2026-06-01
- First posted
- 2024-01-30
- Last updated
- 2026-02-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06231238. Inclusion in this directory is not an endorsement.